Literature DB >> 21055897

Long-term results of Talent endografts for endovascular abdominal aortic aneurysm repair.

Bart A N Verhoeven1, Evert J Waasdorp, Madhu L Gorrepati, Joost A van Herwaarden, Jan Albert Vos, Jan Wille, Frans L Moll, Christopher K Zarins, Jean Paul P M de Vries.   

Abstract

BACKGROUND: Since the introduction of endovascular aneurysm repair (EVAR), long-term follow-up studies reporting single-device results are scarce. In this study, we focus on EVAR repair with the Talent stent graft (Medtronic, Santa Rosa, Calif).
METHODS: Between July 2000 and December 2007, 365 patients underwent elective EVAR with a Talent device. Patient data were gathered prospectively and evaluated retrospectively. By American Society of Anesthesiologists category, 74% were categories III and IV. Postoperative computed tomography (CT) scanning was performed before discharge, at 3, 12 months, and yearly thereafter. Data are presented according to reporting standards for EVAR.
RESULTS: The mean proximal aortic neck diameter was 27 mm (range, 16-36 mm), with a neck length <15 mm in 31% (data available for 193 patients). Deployment of endografts was successful in 361 of 365 patients (99%). Initially, conversion to laparotomy was necessary in four patients. Primary technical success determined by results from computed tomography (CT) scans before discharge was achieved in 333 patients (91%). Proximal type I endoleaks were present in 28 patients (8%) during follow-up, and 14 of these patients needed additional treatment for type I endoleak. The 30-day mortality for the whole Talent group was 1.1% (4 of 365). Follow-up to 84 months is reported for 24 patients. During follow-up, 122 (33%) patients died; in nine, death was abdominal aortic aneurysm (AAA)-related (including 30-day mortality). Kaplan-Meier estimates revealed primary clinical success rates of 98% at 1 year, 93% at 2 years, 88% at 3 years, 79% at 4 years, 64% at 5 years, 51% at 6 years, and 48% at 7 years. Secondary interventions were performed in 73 of 365 patients (20%). Ten conversions for failed endografts were performed. Life-table yearly risk for AAA-related reintervention was 6%, yearly risk for conversion to open repair was 1.1%, yearly risk for total mortality was 8.9%, and yearly risk for AAA-related mortality was 0.8%.
CONCLUSION: Initially, technical success of endovascular aneurysm repair (EVAR) using the Talent endograft is high, with acceptable yearly risk for AAA-related mortality and conversion. However, a substantial amount of mainly endovascular reinterventions is necessary during long-term follow-up to achieve these results.
Copyright © 2011 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21055897     DOI: 10.1016/j.jvs.2010.08.078

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Editor's Choice - Renal complications after EVAR with suprarenal versus infrarenal fixation among all users and routine users.

Authors:  S L Zettervall; S E Deery; P A Soden; K Shean; J J Siracuse; M Alef; V I Patel; M L Schermerhorn
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-08-02       Impact factor: 7.069

Review 2.  A critical appraisal of endovascular stent-grafts in the management of abdominal aortic aneurysms.

Authors:  Nikolaos Schoretsanitis; Efstratios Georgakarakos; Christos Argyriou; Kiriakos Ktenidis; George S Georgiadis
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

3.  Technical and clinical outcome of Talent versus Endurant endografts for endovascular aortic aneurysm repair.

Authors:  Birger Mensel; Jens-Peter Kühn; Tobias Träger; Martin Dührkoop; Wolfram von Bernstorff; Christian Rosenberg; Andreas Hoene; Ralf Puls
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

Review 4.  Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies.

Authors:  S S Bahia; P J E Holt; D Jackson; B O Patterson; R J Hinchliffe; M M Thompson; A Karthikesalingam
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-06-23       Impact factor: 7.069

5.  Early experience with Ovation endograft system in abdominal aortic disease.

Authors:  Giovanni Nano; Daniela Mazzaccaro; Silvia Stegher; Maria Teresa Occhiuto; Giovanni Malacrida; Domenico G Tealdi; Antonino Alberti; Pietro Volpe
Journal:  J Cardiothorac Surg       Date:  2014-03-12       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.